News & Media
Press releases & statements
Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017
May 1, 2017

GAITHERSBURG, Md., May 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2017 financial and operating results following the close of U.S. financial markets on Monday, May 8, 2017.

Conference call details are as follows:

Date: 

 

 

Monday, May 8, 2017

Time: 

 

4:30 p.m. U.S. Eastern Time (ET)

Dial-in number:

 

(877) 212-6076 (Domestic) or (707) 287-9331 (International)

Passcode:

 

15607801

Webcast: 

 

www.novavax.com, “Investors”/ “Events” 

 

Conference call and webcast replay:

Dates: 

 

 

Starting at 7:30 p.m. ET, May 8, 2017, until 7:30 p.m. ET, May 15, 2017 

Dial-in number: 

 

(855) 859-2056 (Domestic) or (404) 537-3406 (International)

Passcode: 

 

15607801

Webcast: 

 

www.novavax.com, “Investors”/ “Events”

 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:

Investor Relations
Novavax, Inc.Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000

Westwicke PartnersJohn Woolfordjohn.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271